Baeyens R, Reyntjens A, Verlinden M
Eur J Clin Pharmacol. 1984;27(3):315-8. doi: 10.1007/BF00542167.
Cisapride (R 51 619) is a newly synthesized compound, which facilitates the release of acetylcholine in the myenteric plexus of the gut. Its effect on gastric emptying of a barium meal was evaluated in 84 patients under randomized, double-blind conditions. Two oral doses (5 mg and 10 mg) of cisapride were compared with a placebo, and two intravenous doses (4 mg and 8 mg) with a placebo and with 10 mg metoclopramide. All doses of cisapride and metoclopramide were significantly superior to placebo in accelerating gastric emptying, intensifying antral contractions and shortening the mouth-to-caecum transit time. The effects of 8 mg cisapride and 10 mg metoclopramide given intravenously were comparable.
西沙必利(R 51 619)是一种新合成的化合物,它可促进肠道肌间神经丛中乙酰胆碱的释放。在随机、双盲条件下,对84例患者评估了其对钡餐胃排空的影响。将西沙必利的两种口服剂量(5毫克和10毫克)与安慰剂进行比较,两种静脉剂量(4毫克和8毫克)与安慰剂以及10毫克甲氧氯普胺进行比较。所有剂量的西沙必利和甲氧氯普胺在加速胃排空、增强胃窦收缩和缩短口至盲肠转运时间方面均显著优于安慰剂。静脉注射8毫克西沙必利和10毫克甲氧氯普胺的效果相当。